Specify a stock or a cryptocurrency in the search bar to get a summary
Oruka Therapeutics, Inc.
ORKAOruka Therapeutics, Inc. operates as a biotechnology company. The Company develops novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis and other inflammatory diseases. Oruka Therapeutics serves patients in the United States. Address:
Analytics
WallStreet Target Price
41.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ORKA
Dividend Analytics ORKA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ORKA
Stock Valuation ORKA
Financials ORKA
Results | 2019 | Dynamics |